Rank | Gene Set | Z-score |
---|---|---|
1 | nuclear pore complex assembly (GO:0051292) | 3.98873428 |
2 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.78439219 |
3 | macrophage activation involved in immune response (GO:0002281) | 3.65453471 |
4 | protein localization to kinetochore (GO:0034501) | 3.64139483 |
5 | nuclear pore organization (GO:0006999) | 3.57826596 |
6 | protein localization to chromosome, centromeric region (GO:0071459) | 3.53978383 |
7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.53243083 |
8 | detection of molecule of bacterial origin (GO:0032490) | 3.52577955 |
9 | mitotic sister chromatid cohesion (GO:0007064) | 3.44880760 |
10 | regulation of interferon-alpha production (GO:0032647) | 3.43886721 |
11 | positive regulation of interferon-alpha production (GO:0032727) | 3.41548502 |
12 | negative regulation of cell killing (GO:0031342) | 3.38059020 |
13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.38059020 |
14 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.37161197 |
15 | pore complex assembly (GO:0046931) | 3.32200639 |
16 | neutrophil mediated immunity (GO:0002446) | 3.29777256 |
17 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.27756593 |
18 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.23987751 |
19 | detection of other organism (GO:0098543) | 3.21878366 |
20 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.16867423 |
21 | defense response to protozoan (GO:0042832) | 3.15154353 |
22 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.12741201 |
23 | cellular response to type I interferon (GO:0071357) | 3.08818645 |
24 | type I interferon signaling pathway (GO:0060337) | 3.08818645 |
25 | response to type I interferon (GO:0034340) | 3.05809444 |
26 | mitotic metaphase plate congression (GO:0007080) | 3.04052364 |
27 | mitotic nuclear envelope disassembly (GO:0007077) | 3.02772399 |
28 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.01138767 |
29 | detection of external biotic stimulus (GO:0098581) | 3.01025692 |
30 | leukocyte aggregation (GO:0070486) | 3.00237133 |
31 | microglial cell activation (GO:0001774) | 2.99708970 |
32 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.97212907 |
33 | DNA replication checkpoint (GO:0000076) | 2.97189145 |
34 | kinetochore organization (GO:0051383) | 2.94225270 |
35 | neutrophil activation (GO:0042119) | 2.93582659 |
36 | mitotic chromosome condensation (GO:0007076) | 2.92777112 |
37 | negative regulation of T cell mediated immunity (GO:0002710) | 2.91961641 |
38 | positive regulation of interferon-beta production (GO:0032728) | 2.91449076 |
39 | regulation of spindle organization (GO:0090224) | 2.90608381 |
40 | response to host immune response (GO:0052572) | 2.90174374 |
41 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.90174374 |
42 | myeloid cell activation involved in immune response (GO:0002275) | 2.89144562 |
43 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.89050526 |
44 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.89050526 |
45 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.88831179 |
46 | T cell migration (GO:0072678) | 2.88569664 |
47 | meiotic chromosome segregation (GO:0045132) | 2.85737071 |
48 | myeloid leukocyte mediated immunity (GO:0002444) | 2.82882946 |
49 | detection of bacterium (GO:0016045) | 2.81922500 |
50 | granulocyte activation (GO:0036230) | 2.80737209 |
51 | germinal center formation (GO:0002467) | 2.80181273 |
52 | membrane disassembly (GO:0030397) | 2.79583161 |
53 | nuclear envelope disassembly (GO:0051081) | 2.79583161 |
54 | DNA unwinding involved in DNA replication (GO:0006268) | 2.78888225 |
55 | macrophage activation (GO:0042116) | 2.78320594 |
56 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.78156419 |
57 | positive regulation of chromosome segregation (GO:0051984) | 2.76125543 |
58 | negative regulation of phagocytosis (GO:0050765) | 2.75161237 |
59 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.74646207 |
60 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.74475720 |
61 | response to interleukin-15 (GO:0070672) | 2.74127143 |
62 | positive regulation of B cell differentiation (GO:0045579) | 2.73307109 |
63 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.72994982 |
64 | histone H3-K36 demethylation (GO:0070544) | 2.71521133 |
65 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.70943422 |
66 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.70794844 |
67 | response to host (GO:0075136) | 2.70794844 |
68 | response to host defenses (GO:0052200) | 2.70794844 |
69 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.70445176 |
70 | regulation of DNA endoreduplication (GO:0032875) | 2.69832997 |
71 | detection of biotic stimulus (GO:0009595) | 2.69304759 |
72 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.68418336 |
73 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.68054366 |
74 | DNA replication initiation (GO:0006270) | 2.66861214 |
75 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.65867760 |
76 | metaphase plate congression (GO:0051310) | 2.63982374 |
77 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.63380406 |
78 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.63358162 |
79 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.63245909 |
80 | sister chromatid segregation (GO:0000819) | 2.63162710 |
81 | interferon-gamma production (GO:0032609) | 2.63145682 |
82 | regulation of RNA export from nucleus (GO:0046831) | 2.61710326 |
83 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.61016451 |
84 | immunoglobulin mediated immune response (GO:0016064) | 2.59855418 |
85 | DNA strand elongation (GO:0022616) | 2.59833453 |
86 | mitotic sister chromatid segregation (GO:0000070) | 2.59659033 |
87 | regulation of interferon-beta production (GO:0032648) | 2.59320071 |
88 | negative regulation of B cell proliferation (GO:0030889) | 2.58994997 |
89 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.58901811 |
90 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.58901811 |
91 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.58901811 |
92 | regulation of histone H3-K9 methylation (GO:0051570) | 2.58002122 |
93 | regulation of mitotic spindle organization (GO:0060236) | 2.57664089 |
94 | telomere maintenance via recombination (GO:0000722) | 2.57643242 |
95 | establishment of chromosome localization (GO:0051303) | 2.56976873 |
96 | positive thymic T cell selection (GO:0045059) | 2.56361726 |
97 | negative regulation of interleukin-12 production (GO:0032695) | 2.55921967 |
98 | hepatocyte apoptotic process (GO:0097284) | 2.55917321 |
99 | mitotic recombination (GO:0006312) | 2.55858415 |
100 | natural killer cell mediated immunity (GO:0002228) | 2.55404207 |
101 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.55404207 |
102 | response to peptidoglycan (GO:0032494) | 2.55401934 |
103 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.54002017 |
104 | regulation of B cell differentiation (GO:0045577) | 2.53860614 |
105 | positive regulation of granulocyte differentiation (GO:0030854) | 2.53814709 |
106 | protein localization to chromosome (GO:0034502) | 2.53389713 |
107 | NIK/NF-kappaB signaling (GO:0038061) | 2.53324580 |
108 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.53081095 |
109 | regulation of tolerance induction (GO:0002643) | 2.51927780 |
110 | histone H3-K4 trimethylation (GO:0080182) | 2.51507579 |
111 | B cell proliferation (GO:0042100) | 2.50754123 |
112 | necroptotic process (GO:0070266) | 2.49796944 |
113 | tolerance induction (GO:0002507) | 2.47543694 |
114 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.47062695 |
115 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.46062995 |
116 | positive regulation of isotype switching (GO:0045830) | 2.45229254 |
117 | regulation of interleukin-12 production (GO:0032655) | 2.44844023 |
118 | regulation of gamma-delta T cell activation (GO:0046643) | 2.44777046 |
119 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.44770904 |
120 | translesion synthesis (GO:0019985) | 2.44379860 |
121 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.43739966 |
122 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.43699859 |
123 | T-helper 1 type immune response (GO:0042088) | 2.43682715 |
124 | DNA topological change (GO:0006265) | 2.43525634 |
125 | negative regulation of growth of symbiont in host (GO:0044130) | 2.43498234 |
126 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.43498234 |
127 | regulation of growth of symbiont in host (GO:0044126) | 2.43498234 |
128 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.35891725 |
129 | negative thymic T cell selection (GO:0045060) | 2.35497798 |
130 | cellular extravasation (GO:0045123) | 2.35234064 |
131 | myeloid dendritic cell activation (GO:0001773) | 2.33808707 |
132 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.33522082 |
133 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.33522082 |
134 | modulation by symbiont of host immune response (GO:0052553) | 2.33522082 |
135 | positive regulation by symbiont of host defense response (GO:0052509) | 2.33522082 |
136 | modulation by symbiont of host defense response (GO:0052031) | 2.33522082 |
137 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.33522082 |
138 | negative T cell selection (GO:0043383) | 2.32926453 |
139 | regulation of necroptotic process (GO:0060544) | 2.32841574 |
140 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.32630095 |
141 | DNA replication-independent nucleosome organization (GO:0034724) | 2.32630095 |
142 | B cell receptor signaling pathway (GO:0050853) | 2.31895677 |
143 | response to muramyl dipeptide (GO:0032495) | 2.31703727 |
144 | ribosomal small subunit assembly (GO:0000028) | 2.31544359 |
145 | CENP-A containing nucleosome assembly (GO:0034080) | 2.30880759 |
146 | chromatin remodeling at centromere (GO:0031055) | 2.30848071 |
147 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.30704270 |
148 | kinetochore assembly (GO:0051382) | 2.29779852 |
149 | B cell mediated immunity (GO:0019724) | 2.29736788 |
150 | dosage compensation (GO:0007549) | 2.29452782 |
151 | response to protozoan (GO:0001562) | 2.29168029 |
152 | DNA duplex unwinding (GO:0032508) | 2.28644099 |
153 | nuclear envelope organization (GO:0006998) | 2.28630428 |
154 | neutrophil activation involved in immune response (GO:0002283) | 2.27418314 |
155 | DNA geometric change (GO:0032392) | 2.27272261 |
156 | negative regulation of histone methylation (GO:0031061) | 2.26328673 |
157 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.25539412 |
158 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.24919598 |
159 | respiratory burst (GO:0045730) | 2.24501569 |
160 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.22629902 |
161 | chromatin assembly or disassembly (GO:0006333) | 2.22346970 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.66655759 |
2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.60469406 |
3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.55538673 |
4 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.43070964 |
5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.90382451 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.85195349 |
7 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.80074954 |
8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.65990044 |
9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.43516699 |
10 | * MYC_22102868_ChIP-Seq_BL_Human | 2.39569240 |
11 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.36004705 |
12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.35303799 |
13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.32487754 |
14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.23946219 |
15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.22981090 |
16 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.18428297 |
17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.10918536 |
18 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.10695612 |
19 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.09752145 |
20 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.07929273 |
21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.98768006 |
22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.96541049 |
23 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.96406572 |
24 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.95534895 |
25 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.94557779 |
26 | MYB_26560356_Chip-Seq_TH2_Human | 1.91625574 |
27 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.89418882 |
28 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.89275869 |
29 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.85981812 |
30 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.85184266 |
31 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.85149421 |
32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.84962901 |
33 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.83505762 |
34 | * MYB_26560356_Chip-Seq_TH1_Human | 1.79837565 |
35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.76162232 |
36 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.75968655 |
37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.66887197 |
38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.66259130 |
39 | * MAF_26560356_Chip-Seq_TH1_Human | 1.64965117 |
40 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.63437239 |
41 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.62030601 |
42 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.61012276 |
43 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.59980651 |
44 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.54278822 |
45 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51144272 |
46 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.50801744 |
47 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.49632969 |
48 | GATA3_26560356_Chip-Seq_TH2_Human | 1.49414601 |
49 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49051436 |
50 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.48332235 |
51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.46300338 |
52 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.43455305 |
53 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.43273304 |
54 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.42121712 |
55 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.40709016 |
56 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.39755773 |
57 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.39165347 |
58 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37503832 |
59 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.36538382 |
60 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.35471306 |
61 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.32964549 |
62 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.30829482 |
63 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.30026495 |
64 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.28261079 |
65 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.27896025 |
66 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.27562685 |
67 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.27419052 |
68 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.27021779 |
69 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.26882060 |
70 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26220189 |
71 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.20159666 |
72 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.19825437 |
73 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.19200100 |
74 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18355927 |
75 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.17254684 |
76 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.16250216 |
77 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.15998253 |
78 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.13555105 |
79 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.13505654 |
80 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12361368 |
81 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11861831 |
82 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.11371063 |
83 | * MAF_26560356_Chip-Seq_TH2_Human | 1.10652697 |
84 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.10540092 |
85 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.08216332 |
86 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.07567074 |
87 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.07072387 |
88 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.05894415 |
89 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05189772 |
90 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05045875 |
91 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03166555 |
92 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.02584359 |
93 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.00368042 |
94 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.00199753 |
95 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.98869227 |
96 | * TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.98639326 |
97 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98255845 |
98 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97924993 |
99 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.97736450 |
100 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.96518510 |
101 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.96077712 |
102 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.95808372 |
103 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95711784 |
104 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.94843069 |
105 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94232203 |
106 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.94101366 |
107 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.94042603 |
108 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.93688155 |
109 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92220758 |
110 | SPI1_23127762_ChIP-Seq_K562_Human | 0.91785523 |
111 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.91117401 |
112 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.88719736 |
113 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86909733 |
114 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.86467525 |
115 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.85375912 |
116 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.85243606 |
117 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81044481 |
118 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.80566935 |
119 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.77840158 |
120 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.77840158 |
121 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.77541886 |
122 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.77279215 |
123 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.76674524 |
124 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76210465 |
125 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.73167418 |
126 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.72666809 |
127 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.72230951 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003693_abnormal_embryo_hatching | 3.30872609 |
2 | MP0001835_abnormal_antigen_presentation | 3.03114810 |
3 | MP0008057_abnormal_DNA_replication | 2.97748322 |
4 | MP0003303_peritoneal_inflammation | 2.82945528 |
5 | MP0010094_abnormal_chromosome_stability | 2.76232299 |
6 | MP0002396_abnormal_hematopoietic_system | 2.73796319 |
7 | MP0003111_abnormal_nucleus_morphology | 2.59852885 |
8 | MP0001800_abnormal_humoral_immune | 2.41861312 |
9 | MP0005671_abnormal_response_to | 2.33276274 |
10 | MP0003077_abnormal_cell_cycle | 2.32913849 |
11 | MP0003436_decreased_susceptibility_to | 2.30201331 |
12 | MP0002452_abnormal_antigen_presenting | 2.16301839 |
13 | MP0003763_abnormal_thymus_physiology | 2.14982148 |
14 | MP0001790_abnormal_immune_system | 2.09674869 |
15 | MP0005387_immune_system_phenotype | 2.09674869 |
16 | MP0005000_abnormal_immune_tolerance | 2.07849462 |
17 | MP0000685_abnormal_immune_system | 2.05125697 |
18 | MP0004808_abnormal_hematopoietic_stem | 2.03921024 |
19 | MP0002398_abnormal_bone_marrow | 2.01341104 |
20 | MP0004957_abnormal_blastocyst_morpholog | 2.00712293 |
21 | MP0010307_abnormal_tumor_latency | 1.99358982 |
22 | MP0002723_abnormal_immune_serum | 1.99300226 |
23 | MP0009785_altered_susceptibility_to | 1.98574717 |
24 | MP0002420_abnormal_adaptive_immunity | 1.96542645 |
25 | MP0001819_abnormal_immune_cell | 1.95396835 |
26 | MP0010352_gastrointestinal_tract_polyps | 1.93649706 |
27 | MP0003656_abnormal_erythrocyte_physiolo | 1.92190046 |
28 | MP0005397_hematopoietic_system_phenotyp | 1.89479356 |
29 | MP0001545_abnormal_hematopoietic_system | 1.89479356 |
30 | MP0003300_gastrointestinal_ulcer | 1.87869894 |
31 | MP0009333_abnormal_splenocyte_physiolog | 1.87015352 |
32 | MP0005025_abnormal_response_to | 1.85685786 |
33 | MP0008058_abnormal_DNA_repair | 1.85418707 |
34 | MP0002419_abnormal_innate_immunity | 1.85106314 |
35 | MP0002166_altered_tumor_susceptibility | 1.85002611 |
36 | MP0005076_abnormal_cell_differentiation | 1.79861175 |
37 | MP0005451_abnormal_body_composition | 1.78806098 |
38 | MP0002405_respiratory_system_inflammati | 1.75036466 |
39 | MP0000716_abnormal_immune_system | 1.73741184 |
40 | MP0002006_tumorigenesis | 1.71244058 |
41 | MP0000490_abnormal_crypts_of | 1.71179150 |
42 | MP0002148_abnormal_hypersensitivity_rea | 1.67916569 |
43 | MP0000689_abnormal_spleen_morphology | 1.66307907 |
44 | MP0002722_abnormal_immune_system | 1.65186038 |
45 | MP0008007_abnormal_cellular_replicative | 1.64382224 |
46 | MP0004381_abnormal_hair_follicle | 1.60208514 |
47 | MP0001873_stomach_inflammation | 1.57990847 |
48 | MP0001853_heart_inflammation | 1.53923886 |
49 | MP0002429_abnormal_blood_cell | 1.53262197 |
50 | MP0000703_abnormal_thymus_morphology | 1.51428620 |
51 | MP0010155_abnormal_intestine_physiology | 1.50593284 |
52 | MP0005464_abnormal_platelet_physiology | 1.50186589 |
53 | MP0004947_skin_inflammation | 1.43815714 |
54 | MP0009278_abnormal_bone_marrow | 1.43331700 |
55 | MP0008877_abnormal_DNA_methylation | 1.36384684 |
56 | MP0008260_abnormal_autophagy | 1.34816263 |
57 | MP0009764_decreased_sensitivity_to | 1.34097441 |
58 | MP0000350_abnormal_cell_proliferation | 1.31160246 |
59 | MP0001845_abnormal_inflammatory_respons | 1.30793679 |
60 | MP0002019_abnormal_tumor_incidence | 1.30245601 |
61 | MP0003448_altered_tumor_morphology | 1.28722636 |
62 | MP0000569_abnormal_digit_pigmentation | 1.25994468 |
63 | MP0000858_altered_metastatic_potential | 1.25835212 |
64 | MP0003724_increased_susceptibility_to | 1.19862522 |
65 | MP0001730_embryonic_growth_arrest | 1.19759661 |
66 | MP0003172_abnormal_lysosome_physiology | 1.15887967 |
67 | MP0005174_abnormal_tail_pigmentation | 1.14808937 |
68 | MP0006082_CNS_inflammation | 1.13423602 |
69 | MP0000465_gastrointestinal_hemorrhage | 1.12995208 |
70 | MP0003566_abnormal_cell_adhesion | 1.11953614 |
71 | MP0003191_abnormal_cellular_cholesterol | 1.11628826 |
72 | MP0004185_abnormal_adipocyte_glucose | 1.09775492 |
73 | MP0005075_abnormal_melanosome_morpholog | 1.05076176 |
74 | MP0003221_abnormal_cardiomyocyte_apopto | 1.01616351 |
75 | MP0000313_abnormal_cell_death | 1.01579781 |
76 | MP0001533_abnormal_skeleton_physiology | 1.01527476 |
77 | MP0008932_abnormal_embryonic_tissue | 1.00326222 |
78 | MP0004264_abnormal_extraembryonic_tissu | 0.97269262 |
79 | MP0004883_abnormal_blood_vessel | 0.96263023 |
80 | MP0003183_abnormal_peptide_metabolism | 0.94933131 |
81 | MP0001672_abnormal_embryogenesis/_devel | 0.94001278 |
82 | MP0005380_embryogenesis_phenotype | 0.94001278 |
83 | MP0003786_premature_aging | 0.93236140 |
84 | MP0003984_embryonic_growth_retardation | 0.93119434 |
85 | MP0005164_abnormal_response_to | 0.93099862 |
86 | MP0002088_abnormal_embryonic_growth/wei | 0.91377331 |
87 | MP0005310_abnormal_salivary_gland | 0.88629275 |
88 | MP0003866_abnormal_defecation | 0.88474003 |
89 | MP0002086_abnormal_extraembryonic_tissu | 0.86670814 |
90 | MP0008469_abnormal_protein_level | 0.86023156 |
91 | MP0004510_myositis | 0.85954794 |
92 | MP0003828_pulmonary_edema | 0.85642431 |
93 | MP0003453_abnormal_keratinocyte_physiol | 0.83511093 |
94 | MP0005023_abnormal_wound_healing | 0.83164252 |
95 | MP0008004_abnormal_stomach_pH | 0.80315267 |
96 | MP0002877_abnormal_melanocyte_morpholog | 0.79930104 |
97 | MP0002998_abnormal_bone_remodeling | 0.79924240 |
98 | MP0001851_eye_inflammation | 0.79256357 |
99 | MP0001697_abnormal_embryo_size | 0.78572401 |
100 | MP0002080_prenatal_lethality | 0.76792510 |
101 | MP0003091_abnormal_cell_migration | 0.76475330 |
102 | MP0001216_abnormal_epidermal_layer | 0.76233315 |
103 | MP0002009_preneoplasia | 0.75828978 |
104 | MP0002095_abnormal_skin_pigmentation | 0.75527844 |
105 | MP0009763_increased_sensitivity_to | 0.75205364 |
106 | MP0002933_joint_inflammation | 0.74397477 |
107 | MP0010234_abnormal_vibrissa_follicle | 0.73652466 |
108 | MP0000015_abnormal_ear_pigmentation | 0.73615647 |
109 | MP0006054_spinal_hemorrhage | 0.72714172 |
110 | MP0005058_abnormal_lysosome_morphology | 0.71609530 |
111 | MP0005621_abnormal_cell_physiology | 0.69550985 |
112 | MP0002332_abnormal_exercise_endurance | 0.68341383 |
113 | MP0009765_abnormal_xenobiotic_induced | 0.67815979 |
114 | MP0000627_abnormal_mammary_gland | 0.67753996 |
115 | MP0000733_abnormal_muscle_development | 0.64941257 |
116 | MP0004197_abnormal_fetal_growth/weight/ | 0.62983876 |
117 | MP0003705_abnormal_hypodermis_morpholog | 0.62915732 |
118 | MP0009931_abnormal_skin_appearance | 0.60297975 |
119 | MP0000377_abnormal_hair_follicle | 0.59378539 |
120 | MP0000383_abnormal_hair_follicle | 0.58989382 |
121 | MP0000371_diluted_coat_color | 0.58839587 |
122 | MP0002132_abnormal_respiratory_system | 0.58803131 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 4.13623605 |
2 | Recurrent abscess formation (HP:0002722) | 4.08664061 |
3 | Recurrent bacterial skin infections (HP:0005406) | 3.77326650 |
4 | Recurrent viral infections (HP:0004429) | 3.63561804 |
5 | Recurrent fungal infections (HP:0002841) | 3.57384496 |
6 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.55718262 |
7 | Obstructive lung disease (HP:0006536) | 3.41341343 |
8 | Chronic obstructive pulmonary disease (HP:0006510) | 3.41341343 |
9 | IgM deficiency (HP:0002850) | 3.22094909 |
10 | Chromsome breakage (HP:0040012) | 3.21498171 |
11 | Keratoconjunctivitis (HP:0001096) | 3.17193209 |
12 | Myositis (HP:0100614) | 3.13447632 |
13 | Thrombocytosis (HP:0001894) | 3.12795492 |
14 | Mediastinal lymphadenopathy (HP:0100721) | 3.07798116 |
15 | Cellulitis (HP:0100658) | 3.01948169 |
16 | Abnormality of the fingertips (HP:0001211) | 2.96461329 |
17 | Autoimmune hemolytic anemia (HP:0001890) | 2.95348522 |
18 | Recurrent bronchitis (HP:0002837) | 2.90582543 |
19 | Meningitis (HP:0001287) | 2.88006491 |
20 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.86254535 |
21 | Retrobulbar optic neuritis (HP:0100654) | 2.74034183 |
22 | Optic neuritis (HP:0100653) | 2.74034183 |
23 | Vasculitis (HP:0002633) | 2.72999757 |
24 | Pustule (HP:0200039) | 2.70182215 |
25 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.70056699 |
26 | Recurrent cutaneous fungal infections (HP:0011370) | 2.70056699 |
27 | Abnormality of B cell number (HP:0010975) | 2.68840025 |
28 | B lymphocytopenia (HP:0010976) | 2.68840025 |
29 | Abnormality of the prostate (HP:0008775) | 2.64717484 |
30 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.62360257 |
31 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.61452636 |
32 | T lymphocytopenia (HP:0005403) | 2.61050021 |
33 | Acute myeloid leukemia (HP:0004808) | 2.60003453 |
34 | Recurrent skin infections (HP:0001581) | 2.59538849 |
35 | Abnormality of T cells (HP:0002843) | 2.58171278 |
36 | Orchitis (HP:0100796) | 2.56907844 |
37 | Gangrene (HP:0100758) | 2.56863667 |
38 | Autoimmune thrombocytopenia (HP:0001973) | 2.55855517 |
39 | Eosinophilia (HP:0001880) | 2.54649893 |
40 | Abnormality of T cell number (HP:0011839) | 2.53404407 |
41 | Entropion (HP:0000621) | 2.52330854 |
42 | Abnormality of chromosome stability (HP:0003220) | 2.51472482 |
43 | Abnormality of T cell physiology (HP:0011840) | 2.50265829 |
44 | Chronic otitis media (HP:0000389) | 2.49243704 |
45 | Gingival bleeding (HP:0000225) | 2.44911420 |
46 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.43660133 |
47 | Reticulocytopenia (HP:0001896) | 2.41939409 |
48 | Papillary thyroid carcinoma (HP:0002895) | 2.37458804 |
49 | Lymphopenia (HP:0001888) | 2.35723800 |
50 | IgG deficiency (HP:0004315) | 2.34905412 |
51 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.33921727 |
52 | Agammaglobulinemia (HP:0004432) | 2.33683722 |
53 | Prominent nose (HP:0000448) | 2.33324250 |
54 | Lymphoma (HP:0002665) | 2.32564371 |
55 | Periodontitis (HP:0000704) | 2.31902661 |
56 | Nasal polyposis (HP:0100582) | 2.31580602 |
57 | Leukocytosis (HP:0001974) | 2.31123829 |
58 | IgA deficiency (HP:0002720) | 2.30621416 |
59 | Myelodysplasia (HP:0002863) | 2.30150985 |
60 | Pulmonary infiltrates (HP:0002113) | 2.29886378 |
61 | Prolonged bleeding time (HP:0003010) | 2.28483380 |
62 | Recurrent sinusitis (HP:0011108) | 2.27545673 |
63 | Panhypogammaglobulinemia (HP:0003139) | 2.26903090 |
64 | Birth length less than 3rd percentile (HP:0003561) | 2.26246767 |
65 | Granulocytopenia (HP:0001913) | 2.26125959 |
66 | Arterial thrombosis (HP:0004420) | 2.24132782 |
67 | Urticaria (HP:0001025) | 2.24073675 |
68 | Gingivitis (HP:0000230) | 2.24002153 |
69 | Osteomyelitis (HP:0002754) | 2.23673697 |
70 | Subacute progressive viral hepatitis (HP:0006572) | 2.23557920 |
71 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.23099617 |
72 | Osteolytic defects of the hand bones (HP:0009699) | 2.23099617 |
73 | Ectopic kidney (HP:0000086) | 2.21415650 |
74 | Viral hepatitis (HP:0006562) | 2.20686536 |
75 | Stomatitis (HP:0010280) | 2.17815433 |
76 | Volvulus (HP:0002580) | 2.17459649 |
77 | Thyroiditis (HP:0100646) | 2.17047219 |
78 | Epistaxis (HP:0000421) | 2.16768983 |
79 | Abnormality of macrophages (HP:0004311) | 2.16721672 |
80 | Petechiae (HP:0000967) | 2.15761271 |
81 | Amaurosis fugax (HP:0100576) | 2.15295956 |
82 | Spinal cord lesions (HP:0100561) | 2.14363005 |
83 | Syringomyelia (HP:0003396) | 2.14363005 |
84 | Hemoptysis (HP:0002105) | 2.12829441 |
85 | Deep philtrum (HP:0002002) | 2.12644963 |
86 | Leukopenia (HP:0001882) | 2.12619337 |
87 | Abnormality of eosinophils (HP:0001879) | 2.12074188 |
88 | Pulmonary fibrosis (HP:0002206) | 2.11368157 |
89 | Inflammation of the large intestine (HP:0002037) | 2.11310404 |
90 | Abnormality of the preputium (HP:0100587) | 2.10541965 |
91 | Encephalitis (HP:0002383) | 2.10209005 |
92 | Recurrent pneumonia (HP:0006532) | 2.08260223 |
93 | Colitis (HP:0002583) | 2.07134835 |
94 | Abnormality of the pleura (HP:0002103) | 2.05509786 |
95 | Combined immunodeficiency (HP:0005387) | 2.05320974 |
96 | Gastrointestinal inflammation (HP:0004386) | 2.03805571 |
97 | Abnormality of the peritoneum (HP:0002585) | 2.01366706 |
98 | Facial hemangioma (HP:0000329) | 2.00353246 |
99 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.99471830 |
100 | Clubbing of toes (HP:0100760) | 1.99207392 |
101 | Gastrointestinal infarctions (HP:0005244) | 1.98682870 |
102 | Anorexia (HP:0002039) | 1.98459348 |
103 | Increased IgM level (HP:0003496) | 1.98425908 |
104 | Slow saccadic eye movements (HP:0000514) | 1.97705270 |
105 | Severe combined immunodeficiency (HP:0004430) | 1.96758666 |
106 | Keratoconjunctivitis sicca (HP:0001097) | 1.96685291 |
107 | Increased IgE level (HP:0003212) | 1.96599871 |
108 | Cutaneous melanoma (HP:0012056) | 1.95587364 |
109 | Glomerulopathy (HP:0100820) | 1.95440540 |
110 | Skin ulcer (HP:0200042) | 1.95310611 |
111 | Prostate neoplasm (HP:0100787) | 1.93309648 |
112 | Chest pain (HP:0100749) | 1.93212103 |
113 | Meckel diverticulum (HP:0002245) | 1.91331094 |
114 | Spontaneous hematomas (HP:0007420) | 1.89972086 |
115 | Impulsivity (HP:0100710) | 1.88601950 |
116 | Recurrent lower respiratory tract infections (HP:0002783) | 1.88259288 |
117 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.87799880 |
118 | Poikiloderma (HP:0001029) | 1.87769258 |
119 | Acute lymphatic leukemia (HP:0006721) | 1.86947002 |
120 | Pulmonary embolism (HP:0002204) | 1.85769751 |
121 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.85184594 |
122 | Fatigue (HP:0012378) | 1.84865707 |
123 | Abnormal number of erythroid precursors (HP:0012131) | 1.84592476 |
124 | Abnormal platelet volume (HP:0011876) | 1.83887428 |
125 | Verrucae (HP:0200043) | 1.82916703 |
126 | Disinhibition (HP:0000734) | 1.81303958 |
127 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.80392889 |
128 | Abnormal foot bone ossification (HP:0010675) | 1.76263072 |
129 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.74486143 |
130 | Keratitis (HP:0000491) | 1.74400372 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 3.67038681 |
2 | CDC7 | 2.79126004 |
3 | NEK2 | 2.45062407 |
4 | TXK | 2.44758119 |
5 | CDK12 | 2.35472695 |
6 | STK10 | 2.24422074 |
7 | IRAK4 | 2.12961933 |
8 | WEE1 | 2.09622275 |
9 | MAP3K14 | 2.06627591 |
10 | JAK3 | 1.93043012 |
11 | EIF2AK1 | 1.80779464 |
12 | TAOK3 | 1.77274596 |
13 | BLK | 1.75442921 |
14 | RPS6KA4 | 1.71694354 |
15 | EEF2K | 1.69974340 |
16 | MAP3K13 | 1.66983355 |
17 | TYK2 | 1.65321860 |
18 | PLK4 | 1.63701985 |
19 | IRAK3 | 1.61674171 |
20 | PIM1 | 1.56129164 |
21 | SRPK1 | 1.55391096 |
22 | FGR | 1.52548134 |
23 | IRAK1 | 1.51727461 |
24 | TEC | 1.47443079 |
25 | BMPR2 | 1.46812058 |
26 | PRPF4B | 1.46577573 |
27 | BUB1 | 1.43801153 |
28 | ZAP70 | 1.42721121 |
29 | BTK | 1.41510996 |
30 | MATK | 1.41041431 |
31 | BRSK2 | 1.41007030 |
32 | STK3 | 1.40904850 |
33 | CDK4 | 1.38081921 |
34 | IRAK2 | 1.37376821 |
35 | STK4 | 1.36180248 |
36 | IKBKB | 1.36160628 |
37 | TBK1 | 1.33016982 |
38 | MAP3K10 | 1.30454894 |
39 | YES1 | 1.27746614 |
40 | ATR | 1.26699608 |
41 | CDK6 | 1.26209631 |
42 | NUAK1 | 1.25095392 |
43 | AURKB | 1.19740523 |
44 | PIM2 | 1.17724910 |
45 | NME2 | 1.13630156 |
46 | CAMK1G | 1.13496973 |
47 | EIF2AK3 | 1.12377070 |
48 | ITK | 1.12090205 |
49 | IKBKE | 1.08546699 |
50 | CLK1 | 1.08522484 |
51 | MAP3K8 | 1.08029869 |
52 | SYK | 1.07704116 |
53 | TTK | 1.05883296 |
54 | JAK1 | 1.05492743 |
55 | CHUK | 1.05402137 |
56 | KSR1 | 1.05016605 |
57 | LRRK2 | 1.04356931 |
58 | CSF1R | 1.03814071 |
59 | NEK9 | 1.02978647 |
60 | CSK | 1.02871438 |
61 | MKNK2 | 1.02839557 |
62 | GRK6 | 1.01532371 |
63 | MST4 | 1.00846203 |
64 | TAOK1 | 1.00494084 |
65 | KIT | 1.00299727 |
66 | MARK3 | 0.98398248 |
67 | HCK | 0.95806473 |
68 | CDK7 | 0.95197519 |
69 | PLK1 | 0.93673331 |
70 | NEK6 | 0.89625758 |
71 | MKNK1 | 0.88995020 |
72 | RIPK4 | 0.88904752 |
73 | MAP3K3 | 0.88198052 |
74 | * CHEK1 | 0.87878961 |
75 | LCK | 0.87560658 |
76 | TSSK6 | 0.87363701 |
77 | ACVR1B | 0.86447678 |
78 | MAP3K2 | 0.86366096 |
79 | TESK2 | 0.86226990 |
80 | DYRK3 | 0.85753295 |
81 | CHEK2 | 0.85660766 |
82 | FGFR3 | 0.85376310 |
83 | MAP3K1 | 0.85182571 |
84 | ALK | 0.85073521 |
85 | GRK7 | 0.84504394 |
86 | RPS6KB2 | 0.83775387 |
87 | SIK3 | 0.82372227 |
88 | RAF1 | 0.80221366 |
89 | WNK1 | 0.79734576 |
90 | LYN | 0.76378456 |
91 | EIF2AK2 | 0.75361465 |
92 | TLK1 | 0.73768481 |
93 | KSR2 | 0.73643427 |
94 | NLK | 0.72201674 |
95 | ATM | 0.71946540 |
96 | MAP2K3 | 0.71872962 |
97 | ZAK | 0.69741213 |
98 | SMG1 | 0.67531917 |
99 | PLK3 | 0.64939610 |
100 | TTN | 0.63952358 |
101 | TRPM7 | 0.63406941 |
102 | MOS | 0.62297980 |
103 | BRD4 | 0.62032713 |
104 | STK24 | 0.61544945 |
105 | CDK9 | 0.61249065 |
106 | FGFR4 | 0.55870501 |
107 | PDK1 | 0.55139398 |
108 | CDK2 | 0.54534251 |
109 | PIK3CG | 0.54117155 |
110 | JAK2 | 0.53865757 |
111 | TRIB3 | 0.53768983 |
112 | PASK | 0.52789116 |
113 | VRK1 | 0.52198102 |
114 | DMPK | 0.51703712 |
115 | PKN2 | 0.51030695 |
116 | TGFBR2 | 0.50982596 |
117 | EPHB1 | 0.50657855 |
118 | MELK | 0.50171927 |
119 | FES | 0.49430223 |
120 | ERN1 | 0.48113563 |
121 | BRSK1 | 0.46066285 |
122 | TNK2 | 0.45631773 |
123 | MAPKAPK2 | 0.45191453 |
124 | PNCK | 0.44151772 |
125 | ABL1 | 0.43539287 |
126 | SCYL2 | 0.43486035 |
127 | CAMK1D | 0.43338828 |
128 | MAP3K5 | 0.43117834 |
129 | TAOK2 | 0.42107952 |
Rank | Gene Set | Z-score |
---|---|---|
1 | DNA replication_Homo sapiens_hsa03030 | 2.86844189 |
2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.29734162 |
3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.20327420 |
4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.09565096 |
5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.04750629 |
6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.98557816 |
7 | Mismatch repair_Homo sapiens_hsa03430 | 1.98004250 |
8 | Cell cycle_Homo sapiens_hsa04110 | 1.97635508 |
9 | Homologous recombination_Homo sapiens_hsa03440 | 1.97020228 |
10 | Base excision repair_Homo sapiens_hsa03410 | 1.92101979 |
11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.90475464 |
12 | RNA transport_Homo sapiens_hsa03013 | 1.87172190 |
13 | Measles_Homo sapiens_hsa05162 | 1.81559989 |
14 | Spliceosome_Homo sapiens_hsa03040 | 1.79133221 |
15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.77461917 |
16 | Allograft rejection_Homo sapiens_hsa05330 | 1.77417195 |
17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.76565592 |
18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.74177865 |
19 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.72360881 |
20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.64165563 |
21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.63171429 |
22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.60088177 |
23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.56114814 |
24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.54900933 |
25 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.53802068 |
26 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.53329110 |
27 | Asthma_Homo sapiens_hsa05310 | 1.44151544 |
28 | Legionellosis_Homo sapiens_hsa05134 | 1.38291244 |
29 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.37879774 |
30 | Ribosome_Homo sapiens_hsa03010 | 1.37462978 |
31 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.35719485 |
32 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.35308920 |
33 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.32360713 |
34 | RNA polymerase_Homo sapiens_hsa03020 | 1.32024287 |
35 | Apoptosis_Homo sapiens_hsa04210 | 1.28121626 |
36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.28036039 |
37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.27799892 |
38 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.25338628 |
39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.24014010 |
40 | Influenza A_Homo sapiens_hsa05164 | 1.22816380 |
41 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.22705237 |
42 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.20141741 |
43 | Hepatitis B_Homo sapiens_hsa05161 | 1.16351067 |
44 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.15545897 |
45 | Basal transcription factors_Homo sapiens_hsa03022 | 1.14381933 |
46 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.12264364 |
47 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.11943159 |
48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.10899311 |
49 | RNA degradation_Homo sapiens_hsa03018 | 1.10583168 |
50 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.09447344 |
51 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08509863 |
52 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.06913035 |
53 | Malaria_Homo sapiens_hsa05144 | 1.06572977 |
54 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.06118459 |
55 | Tuberculosis_Homo sapiens_hsa05152 | 1.05533548 |
56 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.05454340 |
57 | HTLV-I infection_Homo sapiens_hsa05166 | 1.02602057 |
58 | Shigellosis_Homo sapiens_hsa05131 | 1.02532703 |
59 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.01428214 |
60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.99317632 |
61 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.99124485 |
62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.97905794 |
63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.96106462 |
64 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.94550129 |
65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.90238316 |
66 | Pertussis_Homo sapiens_hsa05133 | 0.89371455 |
67 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86993926 |
68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.84788063 |
69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.84785455 |
70 | Bladder cancer_Homo sapiens_hsa05219 | 0.82060025 |
71 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81576381 |
72 | Proteasome_Homo sapiens_hsa03050 | 0.81338826 |
73 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.80584693 |
74 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.79548986 |
75 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.78457941 |
76 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.77965807 |
77 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.77157660 |
78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69504290 |
79 | Salmonella infection_Homo sapiens_hsa05132 | 0.69010814 |
80 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.68030662 |
81 | Endometrial cancer_Homo sapiens_hsa05213 | 0.67727392 |
82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.66206350 |
83 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.65814056 |
84 | Hepatitis C_Homo sapiens_hsa05160 | 0.65713770 |
85 | Phagosome_Homo sapiens_hsa04145 | 0.65374125 |
86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60962990 |
87 | Platelet activation_Homo sapiens_hsa04611 | 0.59871907 |
88 | Amoebiasis_Homo sapiens_hsa05146 | 0.58815795 |
89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58152002 |
90 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.56947023 |
91 | Prostate cancer_Homo sapiens_hsa05215 | 0.54661680 |
92 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.54427762 |
93 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53860169 |
94 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53816629 |
95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53687171 |
96 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52233073 |
97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51180975 |
98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48968881 |
99 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.48582294 |
100 | Glioma_Homo sapiens_hsa05214 | 0.48546348 |
101 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48508321 |
102 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48247775 |
103 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48207167 |
104 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.46219170 |
105 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.42197619 |
106 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42170204 |
107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.40780535 |
108 | Thyroid cancer_Homo sapiens_hsa05216 | 0.40669803 |
109 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40049661 |
110 | Adherens junction_Homo sapiens_hsa04520 | 0.39361765 |
111 | Colorectal cancer_Homo sapiens_hsa05210 | 0.39102395 |
112 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38883085 |
113 | Purine metabolism_Homo sapiens_hsa00230 | 0.37994917 |
114 | Other glycan degradation_Homo sapiens_hsa00511 | 0.37363547 |
115 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.36185588 |
116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35006552 |